ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Morgan Stanley Pathway Small Mid Cap Equity ETF

Morgan Stanley Pathway Small Mid Cap Equity ETF (MSSM)

48.9821
-0.354
(-0.72%)
Cerrado 15 Diciembre 3:00PM
48.93
-0.0521
(-0.11%)
Fuera de horario: 6:59PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
48.9821
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
19,433
48.77 Rango del Día 49.33
48.93 Rango de 52 semanas 50.43
Precio Anterior
49.3361
Precio de Apertura
49.14
Última hora de negociación
Volumen promedio (3 m)
46,579
Volumen financiero
US$ 951,993
Precio Promedio Ponderado
48.9885

MSSM Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.3979-2.7747121873850.3850.4348.934657949.50338063SP
4-1.3979-2.7747121873850.3850.4348.934657949.50338063SP
12-1.3979-2.7747121873850.3850.4348.934657949.50338063SP
26-1.3979-2.7747121873850.3850.4348.934657949.50338063SP
52-1.3979-2.7747121873850.3850.4348.934657949.50338063SP
156-1.3979-2.7747121873850.3850.4348.934657949.50338063SP
260-1.3979-2.7747121873850.3850.4348.934657949.50338063SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WKEYWISeKey International Holdings AG
US$ 7.84
(139.02%)
75.5M
IPHAInnate Pharma SA
US$ 3.00
(93.55%)
13.59M
AVLDirexion Daily AVGO Bull 2X Shares
US$ 33.67
(48.92%)
642.41k
LOOPLoop Industries Inc
US$ 1.8092
(47.09%)
82.11M
AVGXDefiance Daily Target 2X Long AVGO ETF
US$ 31.49
(46.67%)
3.42M
RPTXRepare Therapeutics Inc
US$ 1.765
(-55.54%)
4.7M
INOInovio Pharmaceuticals Inc New
US$ 2.31
(-38.56%)
9.86M
XXII22nd Century Group Inc
US$ 0.048
(-34.69%)
42.23M
FLGCFlora Growth Corporation
US$ 1.30
(-34.34%)
4.14M
WTOUTime Limited
US$ 0.281
(-32.74%)
3.79M
NVDANVIDIA Corporation
US$ 134.25
(-2.25%)
231.23M
SOUNSoundHound AI Inc
US$ 16.905
(23.66%)
159.56M
TRUGTruGolf Holdings Inc
US$ 0.6794
(30.93%)
141.89M
RGTIRigetti Computing Inc
US$ 7.155
(19.85%)
124.45M
AVGOBroadcom Inc
US$ 224.80
(24.43%)
121.33M
dewophile dewophile 2 minutos hace
Me too. They probably want to see the adult HR data and if Shionogi has comparable challenge data from their L inhibitor before finalizing any plan
ENTA
mrfence mrfence 2 minutos hace
The taking isn't about the sp. It's about the owners equity which is worth book value at the time of the taking.
FNMA
EarningsCentral EarningsCentral 4 minutos hace
AVGO
KILLAZILLA KILLAZILLA 5 minutos hace
"JUST SAYIN'" STUPIDITY!!!!

I HOLD ZERO BAGS OF ANY POS SCAMS RUN BY ANY LYING GRIFTERS!!!!!!!

SILLY MAMALUKE!!!!!
ICTY
uplata uplata 6 minutos hace
Trading in few stocks in market btc related stocks mstr mara coin tsla

Semi side only avgo breakout.


Other stocks all trading range...
mrfence mrfence 7 minutos hace
He never gets any.
FNMA
MartinLutherKing MartinLutherKing 7 minutos hace
EL-22 has also completed a Phase 1 clinical trial in South Korea, where it was shown to be generally well tolerated and safe in healthy volunteers.
ELAB
Slojab Slojab 7 minutos hace
That's based on a sp of $.000001. At $.0001, your stock is worth $5,200. That's a little better. But what you'll eventually be able to sell it for once it gets off the Expert Market and the R/S takes place so trading can resume is the question.
SANP
mrfence mrfence 8 minutos hace
😀😃😄😁😆😅🤣😂
FNMA
JonDoe1 JonDoe1 11 minutos hace
AABB has lied about what the plant costs. Whoever it belongs to.
AABB
BDEZ BDEZ 11 minutos hace
Always...
prototype_101 prototype_101 12 minutos hace
1) The May 2024 ASM presentation clearly showing the 4x200 PIC was IN QUALIFICATIONS on Slide 29, that is 100% FACT

2) KCC's post revealing that investors learned that 4x200 PIC was being SHIPPED TO CUSTOMERS (obviously for Qualifications based on Slide 29 showing the 4x200 PIC was IN
ASM LWLG
JoJr JoJr 16 minutos hace
Vess be holding long teurm...
RDAR
bigstocksnbonds bigstocksnbonds 16 minutos hace
Yes you're doing great and it's great you keep trying!!!!! GREAT JOB!!!!!!!
Kool Aid Man Kool Aid Man 16 minutos hace
That autopsy on Eddie's lies is nearly 15 years old which speaks volumes to any sane, rational person. He's only gotten worse over time which has made anything associated with him radioactive.

http://quicktraders.blogspot.com/2010/02/you-cant-judge-book-by-its-cover-part.html
AURI
mrfence mrfence 17 minutos hace
A taking without compensation is NOT permitted or protected by HERA because it's unconstitutional.

HERA

The court of appeals acknowledged that Section
4617(f)’s bar on judicial intervention does not apply
when FHFA “has acted or proposes to act beyond, or
FNMA
Acme Investments Acme Investments 17 minutos hace
I listened to that interview years ago!! Everything's corrupt but you still have to play the game!!
RDAR
GrandAdmiralThrawn GrandAdmiralThrawn 18 minutos hace
So I have two new plays going into my long term portfolio for the next 4 years.
Drill baby Drill- $PHX-Phx Minerals Class A- $.16 dividend per year
Semiconductors- $TOYO- Toyo Co LTD- The Japanese have always done technology right.
PHX TOYO
Lite Lite 19 minutos hace
My guess, it would be announced after the current Director has left that position.
goodietime goodietime 19 minutos hace
Blah, Blah, Blah...
"any child will tell you that the PAA has been finalized.."

SHOW a document that states what YOU PROCLAIN to be true.
Put up or ... you know the thing...

"do me a favor... dont address any more posts to me..."

How about
COOP
joe botts joe botts 19 minutos hace
How hysterical

..... it's REVOKED
theorysuit theorysuit 22 minutos hace
I'll answer for him since you keep spouting this nonsense about tumor response. Yes, it is common for immunotherapies to use ORR in combination with DOR. RMAT trials are often based on ORR in a line where there are no approved therapies. SMFH, you are rookie a biotech investor, but an expert d
NWBO
Money4Nothing-M4N Money4Nothing-M4N 23 minutos hace
No he hasn't. They had a 10:1 split in 2009.

Surely you know the difference between a split and issuing shares.

https://valueofstocks.com/2022/06/18/share-dilution-vs-stock-split/
KBLB

Su Consulta Reciente

Delayed Upgrade Clock